Editorial

May 9, 2022


Alkali therapy for prevention of acute kidney injury in rhabdomyolysis
Jun-Ya Kaimori, Yusuke Sakaguchi, Yoshitaka Isaka
Kidney Res Clin Pract. 2022;41(5):521-523.

Review Article

June 21, 2022


A new pathological perspective on thrombotic microangiopathy
Yong-Jin Kim
Kidney Res Clin Pract. 2022;41(5):524-532.

Review Article

September 30, 2022


Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies
Verdiana Ravarotto, Giovanni Bertoldi, Lucia Federica Stefanelli, et al.
Kidney Res Clin Pract. 2022;41(5):533-544.

Original Article

September 30, 2022


Pathological validation of the Japanese Renal Pathology Society classification and challenges in predicting renal prognosis in patients with diabetic nephropathy
Taeyeong Kim, Yooujin Kwak, Jun Young Lee, et al.
Kidney Res Clin Pract. 2022;41(5):545-555.

Original Article

May 4, 2022


External validation of the international prediction tool in Korean patients with immunoglobulin A nephropathy
Young Su Joo, Hyung Woo Kim, Chung Hee Baek, et al.
Kidney Res Clin Pract. 2022;41(5):556-566.

Original Article

May 4, 2022


Albuminuria, estimated glomerular filtration rate, and traditional predictors for composite cardiovascular and kidney outcome: a population-based cohort study in Korea
Hae Hyuk Jung
Kidney Res Clin Pract. 2022;41(5):567-579.

Original Article

June 24, 2022


Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
Jung Nam An, Jwa-Kyung Kim, Hyung-Seok Lee, et al.
Kidney Res Clin Pract. 2022;41(5):580-590.

Original Article

June 21, 2022


COVID-19–related clinical outcomes among Korean hemodialysis patients
Hayne Cho Park, Young-Ki Lee, Eunsil Ko, et al.
Kidney Res Clin Pract. 2022;41(5):591-600.

Original Article

May 4, 2022


Ambient carbon monoxide correlates with mortality risk of hemodialysis patients: comparing results of control selection in the case-crossover designs
Hyuk Huh, Ejin Kim, Una Amelia Yoon, et al.
Kidney Res Clin Pract. 2022;41(5):601-610.

Original Article

May 11, 2022


The importance of muscle mass in predicting intradialytic hypotension in patients undergoing maintenance hemodialysis
Hyung Eun Son, Ji Young Ryu, Kyunghoon Lee, et al.
Kidney Res Clin Pract. 2022;41(5):611-622.

Original Article

July 21, 2022


Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
Jun Young Lee, Sung Hwa Kim, Yeon Ho Park, et al.
Kidney Res Clin Pract. 2022;41(5):623-634.

Images in Pratice

September 22, 2022


Ureteral stent infection caused by Candida in a renal transplant recipient
Haeun Lee, Byung Ha Chung, Chul Woo Yang, et al.
Kidney Res Clin Pract. 2022;41(5):635-636.

Editorial
Alkali therapy for prevention of acute kidney injury in rhabdomyolysis
Jun-Ya Kaimori, Yusuke Sakaguchi, Yoshitaka Isaka
Kidney Res Clin Pract. 2022;41(5):521-523.   Published online May 9, 2022
Review Article
A new pathological perspective on thrombotic microangiopathy
Yong-Jin Kim
Kidney Res Clin Pract. 2022;41(5):524-532.   Published online June 21, 2022
Thrombotic microangiopathy (TMA) refers to a condition caused by microvascular injury that includes thrombosis, hemolytic anemia, and thrombocytopenia. There are two classic TMAs, hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura, as well as an atypical HUS (aHUS). aHUS includes a broad spectrum of disorders with diverse etiologies and shares clinical manifestations with classic TMA; however, it frequently lacks typical...
Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies
Verdiana Ravarotto, Giovanni Bertoldi, Lucia Federica Stefanelli, Federico Nalesso, Lorenzo A. Calò
Kidney Res Clin Pract. 2022;41(5):533-544.   Published online September 30, 2022
The high prevalence of cardiovascular disease in patients with chronic kidney disease indicates significant interactions between pathogenic pathways operating in the kidney and heart. These interactions involve all cell types (endothelial cells, smooth muscle cells, macrophages, and others), components of the vasculature, glomeruli, and heart that are susceptible to oxidative damage and structural alterations. A vicious cycle occurs whereby harmful...
Original Article
Pathological validation of the Japanese Renal Pathology Society classification and challenges in predicting renal prognosis in patients with diabetic nephropathy
Taeyeong Kim, Yooujin Kwak, Jun Young Lee, Hanwul Shin, Jae Seok Kim, Jae Won Yang, Minseob Eom
Kidney Res Clin Pract. 2022;41(5):545-555.   Published online September 30, 2022
Background: Diabetic nephropathy (DN) accounts for approximately half of all cases of chronic kidney disease (CKD) and end-stage kidney disease worldwide. The Renal Pathology Society (RPS) classification has been used to predict the renal prognosis in DN. In 2018, the Japanese Renal Pathology Society (JRPS) proposed a comprehensive classification system that included pathological changes in the kidney. The clinical significance...
External validation of the international prediction tool in Korean patients with immunoglobulin A nephropathy
Young Su Joo, Hyung Woo Kim, Chung Hee Baek, Jung Tak Park, Hajeong Lee, Beom Jin Lim, Tae-Hyun Yoo, Kyung Chul Moon, Ho Jun Chin, Shin-Wook Kang, Seung Hyeok Han
Kidney Res Clin Pract. 2022;41(5):556-566.   Published online May 4, 2022
Background: The International IgA Nephropathy Prediction Tool has been recently developed to estimate the progression risk of immunoglobulin A nephropathy (IgAN). This study aimed to evaluate the clinical performance of this prediction tool in a large IgAN cohort in Korea. Methods: The study cohort was comprised of 2,064 patients with biopsy-proven IgAN from four medical centers between March 2012 and...
Albuminuria, estimated glomerular filtration rate, and traditional predictors for composite cardiovascular and kidney outcome: a population-based cohort study in Korea
Hae Hyuk Jung
Kidney Res Clin Pract. 2022;41(5):567-579.   Published online May 4, 2022
Background: Certain pharmacotherapies have shown to be effective for both cardiac and kidney outcomes. Although risk prediction is important in treatment decision-making, few studies have evaluated prediction models for composite cardiovascular and kidney outcomes. Methods: This study included 2,195,341 Korean adults from a nationwide cohort for chronic kidney disease and a representative sample of the general population, with a 9-year...
Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
Jung Nam An, Jwa-Kyung Kim, Hyung-Seok Lee, Sung Gyun Kim, Hyung Jik Kim, Young Rim Song
Kidney Res Clin Pract. 2022;41(5):580-590.   Published online June 24, 2022
Background: Sarcopenia is a prevalent complication in patients with chronic kidney disease and is associated with poor quality of life, morbidity, and mortality. Several candidate biomarkers have been evaluated for this condition. This study assessed the serum cystatin C to creatinine (serum cystatin C/Cr) ratio as a potential biomarker for sarcopenia in patients with non-dialysis-dependent chronic kidney disease. Methods: This...
COVID-19–related clinical outcomes among Korean hemodialysis patients
Hayne Cho Park, Young-Ki Lee, Eunsil Ko, Sungbong Yu, AJin Cho, Do Hyoung Kim, Jinseog Kim, Jang-Hee Cho, Jeonghwan Lee, Dong Ki Kim, Seong Nam Kim, Chul-Woo Yang
Kidney Res Clin Pract. 2022;41(5):591-600.   Published online June 21, 2022
Background: Hemodialysis (HD) patients are more vulnerable to viral epidemics, experiencing higher mortality rates compared to individuals without chronic kidney disease (CKD). This retrospective cohort study sought to demonstrate clinical outcomes and associated factors among coronavirus disease 2019 (COVID-19) confirmed Korean HD patients. Methods: From February 2020 to November 2021, the COVID-19 Task Force Team collected clinical data for HD...
Ambient carbon monoxide correlates with mortality risk of hemodialysis patients: comparing results of control selection in the case-crossover designs
Hyuk Huh, Ejin Kim, Una Amelia Yoon, Mun Jeong Choi, Hyewon Lee, Soie Kwon, Clara Tammy Kim, Dong Ki Kim, Yon Su Kim, Chun Soo Lim, Jung Pyo Lee, Ho Kim, Yong Chul Kim
Kidney Res Clin Pract. 2022;41(5):601-610.   Published online May 4, 2022
Background: Growing evidence suggests that environmental air pollution adversely affects kidney health. To date, the association between carbon monoxide (CO) and mortality in patients with end-stage renal disease (ESRD) has not been examined. Methods: Among 134,478 dialysis patients in the Korean ESRD cohort between 2001 and 2014, 8,130 deceased hemodialysis patients were enrolled, and data were analyzed using bidirectional, unidirectional,...
The importance of muscle mass in predicting intradialytic hypotension in patients undergoing maintenance hemodialysis
Hyung Eun Son, Ji Young Ryu, Kyunghoon Lee, Young Il Choi, Myeong Sung Kim, Inwhee Park, Gyu Tae Shin, Heungsoo Kim, Curie Ahn, Sejoong Kim, Ho Jun Chin, Ki Young Na, Dong-Wan Chae, Soyeon Ahn, Seung Sik Hwang, Jong Cheol Jeong
Kidney Res Clin Pract. 2022;41(5):611-622.   Published online May 11, 2022
Background: Patients undergoing hemodialysis are susceptible to sarcopenia. As intracellular reservoirs of water, skeletal muscles are important contributors to intradialytic hypotension. This study was designed to determine the role of skeletal muscle mass in intradialytic hypotension. Methods: In a cross-sectional study, the body composition of 177 patients was measured immediately after hemodialysis using bioelectrical impedance analysis. The parameters measured were...
Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
Jun Young Lee, Sung Hwa Kim, Yeon Ho Park, Jae Berm Park, Su Hyung Lee, Jaeseok Yang, Myoung Soo Kim, Deok Gie Kim
Kidney Res Clin Pract. 2022;41(5):623-634.   Published online July 21, 2022
Background: Basiliximab (BSX) and antithymocyte globulins (ATGs), are two major immunosuppressive agents commonly used as induction therapy for kidney transplant (KT) recipients. The superiority of ATG over BSX has not been well established, especially in elderly KT recipients with low immunological risk. Methods: A total of 847 elderly (≥60 years old), low-risk KT patients in the Korean Organ Transplantation Registry...
Images in Pratice
Ureteral stent infection caused by Candida in a renal transplant recipient
Haeun Lee, Byung Ha Chung, Chul Woo Yang, In O Sun
Kidney Res Clin Pract. 2022;41(5):635-636.   Published online September 22, 2022

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736    Fax: +82-2-3486-8737    E-mail: registry@ksn.or.kr                

Copyright © 2022 by The Korean Society of Nephrology.

Developed in M2PI

Close layer